- The global orthobiologics market is expanding as patients increasingly opt for minimally invasive procedures and regenerative therapies, driven by their safer and more effective outcomes compared to traditional surgical methods
- Innovations in stem cell therapy and platelet-rich plasma technologies are playing a pivotal role in this growth, offering faster recovery and improved healing, making them increasingly popular among both healthcare providers and patients
- North America is expected to dominate the orthobiologics market with 46.07% share due to strong healthcare system and high demand for orthopedic treatments
- Asia-Pacific is expected to be the fastest growing region in the Orthobiologics market during the forecast period with 7.09% share due to rising aging population and an increase in orthopedic surgeries
- The Viscosupplementation Products segment is expected to dominate the Orthobiologics market with the largest share of 40.5% in 2025 due to the increasing prevalence of osteoarthritis and the growing demand for non-surgical treatment options. Viscosupplementation, which involves the injection of hyaluronic acid into the joints, helps alleviate pain, improve mobility, and enhance the quality of life for patients suffering from joint degeneration
